re: AUPH - Aurinia Pharmaceuticals

I think the chances are really good for fed approval. About half of the drugs that make it to phase 3 at all, file for approval. Approval rates of 80% recently which is ~10% less than historically. .

“Approval applications were filed for 55 percent of the drugs that made it to Phase III testing, and 80 percent of those gained eventual approval, although only about half were approved on their initial FDA review“


...we going to market baby.

Nice! I got a few January 10s myself in my options trading account.

I hope this aged well

I've been playing the ups and downs since mid 2018. Very happy with the result. My grandmother fought lupus for 18 years before it took her remaining energy at 72.

Y'all might I have thought i was joking, but I literally have 10 shares.

I bought them for shits and giggles back in Jan 2018 and just kind of let them sit there. Guess I'll cash out on my $150 long term capital gains profit.

Can anyone give me the cliffs on this? What is it and did one of y'all have inside info/were y'all lucky as shite/or was it undervalued?

quote:

---

Can anyone give me the cliffs on this? What is it and did one of y'all have inside info/were y'all lucky as shite/or was it undervalued?

---

I noticed the ticker on here summer of 2016 and started reading all I could on the stock.

I started my long position in February of 2017 in the 3's and when phase 2 data came out in March of 2017 it ran to 10.54 until the company raised money through a second offering (diluted shares). Many exited at that point with profits around the 7-9 range.

The stock then hung out around 5-6.50 for about two years and has never been able to get back to 7-8 with any consistency until last week.

Phase 3 data dropped after hours today and out of the halt the price went from 19 to 25 to 15 to where it is now, 18.45

Many are thinking BUYOUT from big pharma.

TLDR; it was undervalued, attacked by shorts, and manipulated by a few big owners.

quote:

---

Question about the last 3 months where it dropped from $6 to ~$4 with no real news. Is that thought to be the larger shareholders trying to get a lower cost basis by moving a higher volume of shares before the trial data was known?

---

That's what most think. ILJIN, an Asian company that tried a hostile takeover is who most people suspect. They held 16 million shares at one point.

Congrats to all of you!!!

quote:

---

followed By drinking just off wall street like a true trader. but seriously worst drink selection in America is just off wallstreet.

---

Should have gone to the Dead Rabbit

quote:

---

Should have gone to the Dead Rabbit

---

I do love the dead rabbit but honestly you save a few bucks at Irish american and then only need to stumble next door to Fulton street.